Earnings 12 Mar: PHARM.AS Pharming (EURONEXT) pre-market 07 Mar 2026 what to watch
Pre-market earnings spotlight: PHARM.AS stock at EUR 1.33 ahead of 12 Mar report; forecasts, Meyka grade and price targets
Pre-market earnings spotlight: PHARM.AS stock at EUR 1.33 ahead of 12 Mar report; forecasts, Meyka grade and price targets
BEL share jumps as India’s defence stocks rally on West Asia risk. Nifty Defence Index up over 3% with shipbuilders leading. What this means for BEL, risks, and how investors in India can position now
Intraday: 6573.T stock up 18.18% at JPY 65.00 on 07 Mar 2026 — trading update, valuation and Meyka AI forecast
Intraday analysis of 0509.HK stock at HKD 0.17 on 07 Mar 2026, oversold bounce setup and Meyka AI forecast
Pre-market volume spike for ZPRL.F stock on XETRA at €44.35; Meyka AI grade B and €66.98 forecast
Syracuse University ICE detain case: John Bol Ajak reportedly held at Moshannon Valley Processing Center over visa issues. What it means for student visa policy and enrollment risk.
AIC.CN stock jumps 50% to C$0.54 on CNQ; we analyze drivers, valuation, Meyka forecasts and key risks
Criminal lawyer demand is rising in the US on March 6, 2026. Reputation, mentorship, and assault defense strategies are shaping client intake and ad spend. Key metrics and investor takeaways inside.
C3.ai (AI) NYSE close $9.19 on 06 Mar 2026 — AI stock analysis, valuation, and Meyka AI forecast
Benchmark maintains Buy; JBI analyst rating reiterated March 06, 2026 with estimates unchanged